India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Size

• The India, Nepal, Bangladesh, and Sri Lanka radiotherapy market size was valued at USD 131.81 million in 2024 and is expected to reach USD 347.93 million by 2032, at a CAGR of 12.9% during the forecast period
• The market growth is largely fueled by rising cancer incidence, government initiatives to expand oncology infrastructure, and increasing awareness regarding advanced treatment modalities in these countries
• Furthermore, growing demand for precise, non-invasive cancer treatment and the gradual introduction of linear accelerators and image-guided radiotherapy (IGRT) systems in tertiary hospitals is positioning radiotherapy as a cornerstone of modern cancer therapy. These converging factors are accelerating the adoption of radiotherapy solutions, thereby significantly boosting the industry's growth

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Analysis

• Radiotherapy, a cornerstone of modern cancer treatment involving the use of high-energy radiation to destroy cancer cells, is becoming increasingly vital in South Asia's healthcare landscape as cancer prevalence rises and medical infrastructure evolves across India, Nepal, Bangladesh, and Sri Lanka
• The growing demand for radiotherapy solutions is primarily driven by increasing cancer awareness, government-backed oncology programs, and the establishment of cancer centers equipped with advanced treatment technologies such as linear accelerators and brachytherapy systems
• India dominated the radiotherapy market with the largest revenue share of 75.5% in 2024, supported by a vast network of tertiary hospitals, public-private partnerships, and initiatives under the National Cancer Control Programme, with Tier I and Tier II cities witnessing significant investments in radiotherapy infrastructure
• Bangladesh is expected to be the fastest-growing country in the radiotherapy market during the forecast period due to expanding healthcare access, rising investment in medical technology, and collaborative efforts with international health organizations
• The external beam radiotherapy (EBRT) segment dominated the radiotherapy market with a share of 61% in 2024, owing to its widespread availability, clinical effectiveness, and increasing adoption in both public and private oncology care centers

Report Scope and India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Segmentation

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Trends

Rising Adoption of Advanced Radiotherapy Techniques in Cancer Care

• A significant and accelerating trend in the South Asian radiotherapy market is the increasing adoption of advanced radiotherapy techniques such as intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and stereotactic body radiotherapy (SBRT), especially in tertiary hospitals and cancer institutes across India, Nepal, Bangladesh, and Sri Lanka
• For instance, India’s Tata Memorial Centre and AIIMS have widely adopted IGRT and IMRT protocols, enabling precision targeting of tumors with minimal damage to surrounding tissues. Similarly, Sri Lanka's National Cancer Institute has expanded its access to linear accelerators for advanced treatment delivery
• These advancements are improving treatment efficacy and patient outcomes, particularly for complex and late-stage cancers. The availability of real-time imaging, adaptive planning, and motion tracking further supports the safe and effective use of high-dose radiation in a more targeted manner
• The integration of artificial intelligence and machine learning into radiotherapy planning systems is beginning to emerge, offering improved accuracy in tumor contouring and dose prediction. Countries such as Bangladesh and Nepal are gradually embracing tele-radiotherapy planning systems and software that support remote treatment design and peer review from leading cancer centers
• This growing emphasis on precision oncology and technology-enabled radiotherapy is reshaping treatment standards across South Asia. Consequently, companies such as Elekta and Varian are partnering with local health institutions to supply advanced linear accelerators and training programs
• The demand for advanced radiotherapy solutions is increasing rapidly across both public and private sectors, as oncologists and patients seek higher treatment efficacy, fewer side effects, and greater accessibility to state-of-the-art cancer care

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Dynamics

Driver

Surge in Cancer Cases and Public-Private Healthcare Infrastructure Expansion

• The sharp rise in cancer incidence across India, Nepal, Bangladesh, and Sri Lanka, coupled with efforts to strengthen oncology care infrastructure, is a major driver for radiotherapy market growth in the region
• For instance, India’s National Programme for Prevention and Control of Cancer aims to expand radiotherapy centers in underserved regions. Similarly, Sri Lanka and Bangladesh have received support from the International Atomic Energy Agency (IAEA) for enhancing radiotherapy capacity through funding and training initiatives
• With rising awareness, more patients are seeking timely diagnosis and treatment. Radiotherapy offers a non-invasive, effective, and cost-efficient treatment option that fits well within public health frameworks
• In addition, increasing investments from private hospital chains and the rise of cancer specialty centers are accelerating access to radiotherapy, especially in urban and semi-urban areas. These facilities are now equipping themselves with linear accelerators and brachytherapy units, supporting the decentralization of cancer care

Restraint/Challenge

High Capital Costs and Shortage of Trained Oncology Professionals

• One of the major challenges facing the radiotherapy market in South Asia is the high initial capital expenditure required for establishing radiotherapy facilities, including the procurement of linear accelerators, shielding infrastructure, and treatment planning systems
• For instance, many government hospitals in Bangladesh and Nepal struggle to acquire or maintain advanced radiotherapy equipment due to budget constraints, resulting in limited geographic access to quality treatment
• Furthermore, the shortage of trained radiation oncologists, medical physicists, and technologists poses a significant barrier. In India alone, the doctor-to-patient ratio in oncology remains critically low, and similar workforce shortages are evident in neighboring countries
• Addressing these gaps through targeted training programs, international collaboration, and subsidized technology procurement will be essential for scaling radiotherapy services
• In addition, awareness campaigns and streamlined referral pathways are needed to overcome delays in diagnosis and treatment, especially in rural and lower-income populations. Overcoming these structural and resource-related barriers is crucial for achieving equitable and widespread access to radiotherapy across South Asia

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Scope

The market is segmented on the basis of product and services, type, application, end user, and distribution channel.

• By Product and Services

On the basis of product and services, the radiotherapy market is segmented into services, products, and software. The services segment dominated the market with the largest revenue share in 2024, driven by increasing outsourcing of radiotherapy treatment planning, quality assurance, and dosimetry services, particularly in countries such as India and Sri Lanka where public and private hospitals collaborate with service providers to optimize operations and reduce treatment delays.

The software segment is projected to witness the fastest growth from 2025 to 2032, owing to the rising adoption of treatment planning systems (TPS), AI-based contouring tools, and cloud-based oncology software that enhance precision, speed, and consistency in radiotherapy delivery. Software is increasingly being used to streamline planning workflows and integrate with image-guided and adaptive radiotherapy platforms.

• By Type

On the basis of type, the market is segmented into external-beam radiation therapy, internal radiation therapy, systemic radiotherapy/radiopharmaceuticals, and others. External-beam radiation therapy (EBRT) held the largest market share of 61% in 2024, largely due to its widespread use in both early- and advanced-stage cancers. EBRT technologies such as linear accelerators and IMRT systems are commonly found in leading institutions across India, Bangladesh, and Sri Lanka.

Systemic radiotherapy/radiopharmaceuticals is expected to record the fastest CAGR from 2025 to 2032, fueled by rising demand for targeted cancer therapies using radiolabeled isotopes for conditions such as thyroid, prostate, and bone metastases. This segment is gaining traction as more nuclear medicine centers are established in urban hospitals and research institutions.

• By Application

On the basis of application, the radiotherapy market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others. Breast cancer was the leading application segment in 2024, driven by high prevalence rates among women in India and Sri Lanka, along with early-stage screening and treatment programs. EBRT and brachytherapy are commonly used post-surgery or in combination with chemotherapy.

Lung cancer is projected to grow at the fastest rate during the forecast period, supported by increasing tobacco use in Bangladesh and Nepal, and greater availability of stereotactic radiotherapy for precision treatment.

• By End User

On the basis of end user, the market is segmented into hospitals, radiation therapy centers, specialty clinics, and others. Hospitals accounted for the largest share in 2024, as they remain the primary centers for radiotherapy services across South Asia, supported by national cancer programs and international funding in public healthcare systems.

Radiation therapy centers are expected to witness the fastest growth, driven by private investments and the development of standalone oncology centers with advanced equipment, particularly in India’s urban areas and Bangladesh’s expanding healthcare sector.

• By Distribution Channel

On the basis of distribution channel, the radiotherapy market is segmented into direct tenders, third-party distributors, and others. Direct tenders dominated the market in 2024 due to bulk procurement by government agencies and public hospitals, especially in India and Sri Lanka, where large-scale installations are carried out under central health missions.

Third-party distributors are expected to grow rapidly during the forecast period, owing to increasing private sector involvement and cross-border distribution of radiotherapy devices and isotopes through regional partnerships and medical equipment suppliers.

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Regional Analysis

• India dominated the radiotherapy market with the largest revenue share of 75.5% in 2024, supported by a vast network of tertiary hospitals, public-private partnerships, and initiatives under the National Cancer Control Programme, with Tier I and Tier II cities witnessing significant investments in radiotherapy infrastructure
• Patients and healthcare providers in the region increasingly value the precision, efficiency, and improved outcomes offered by modern radiotherapy technologies such as IMRT, IGRT, and linear accelerators, which are becoming more accessible in urban and semi-urban hospitals
• This growing adoption is further supported by government-backed cancer control programs, international collaborations for equipment and training, and a shift toward centralized and specialized cancer care, positioning radiotherapy as a vital component of cancer treatment strategies throughout the region

The India Radiotherapy Market Insight

The India radiotherapy market accounted for the largest market revenue share in South Asia in 2024, supported by the country’s rising cancer incidence, expanding healthcare infrastructure, and strong public-private sector involvement in oncology care. With the increasing adoption of advanced radiotherapy technologies such as IMRT and IGRT, India has emerged as a regional hub for cancer treatment. National programs and institutional investments in tier-I and tier-II cities are further improving access to high-quality radiotherapy. In addition, collaborations with international medical equipment providers and training programs are enhancing treatment quality and expanding the skilled workforce.

Nepal Radiotherapy Market Insight

The Nepal radiotherapy market is steadily growing, supported by government initiatives to strengthen cancer treatment facilities and increasing public awareness about early diagnosis and radiation-based therapy. Though infrastructure development remains in the early stages, recent upgrades in tertiary hospitals such as Bhaktapur Cancer Hospital and the establishment of radiotherapy units in regional centers are laying the groundwork for improved access. Partnerships with India and international agencies are also enabling the procurement of radiotherapy equipment and professional training, fostering gradual but impactful market expansion.

Bangladesh Radiotherapy Market Insight

The Bangladesh radiotherapy market is expanding at a promising rate, driven by the government’s National Cancer Control Strategy and rising investments in oncology units across public hospitals. Increasing cancer prevalence and the need for affordable treatment options are accelerating demand for radiotherapy, particularly EBRT. The market is also benefitting from collaborations with international organizations such as the IAEA, which have provided technical assistance and infrastructure support. As urban hospitals modernize and rural outreach improves, the radiotherapy market in Bangladesh is poised for sustained growth.

Sri Lanka Radiotherapy Market Insight

The Sri Lanka radiotherapy market is experiencing notable growth, propelled by efforts to decentralize cancer care and improve access to radiotherapy services outside of Colombo. Public hospitals such as the National Cancer Institute have enhanced their facilities with modern linear accelerators and planning software. The government’s commitment to reducing cancer-related mortality through early intervention and high-quality treatment has created favorable conditions for market growth. Ongoing support from global health agencies and regional collaborations is further strengthening the country’s radiotherapy infrastructure and capacity.

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Share

The India, Nepal, Bangladesh, and Sri Lanka Radiotherapy industry is primarily led by well-established companies, including:

• Varian Medical Systems (U.S.)
• Elekta AB (Sweden)
• Accuray Incorporated (U.S.)
• Siemens Healthineers AG (Germany)
• GE HealthCare (U.S.)
• IBA Group (Belgium)
• ViewRay, Inc. (U.S.)
• Theragenics Corporation (U.S.)
• Brainlab AG (Germany)
• Mevion Medical Systems, Inc. (U.S.)
• BD (U.S.)
• Canon Medical Systems Corporation (Japan)
• Hitachi, Ltd. (Japan)
• Panacea Medical Technologies Pvt. Ltd. (India)
• Shenzhen Xingaoyi Medical Equipment Co., Ltd. (China)
• Trivitron Healthcare Pvt. Ltd. (India)
• Toshiba Medical Systems Corporation (Japan)
• HCG – HealthCare Global Enterprises Ltd. (India)
• PTW Freiburg GmbH (Germany)

What are the Recent Developments in India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market?

• In March 2024, the Government of India announced the expansion of its National Cancer Grid (NCG) initiative by integrating 40 new regional cancer centers across the country, many of which are equipped with advanced radiotherapy facilities. This strategic move aims to standardize cancer treatment and enhance access to modern radiotherapy in underserved areas. The initiative underscores India's commitment to building a robust oncology infrastructure capable of addressing the country's growing cancer burden
• In February 2024, Bangladesh's Ministry of Health, in partnership with the International Atomic Energy Agency (IAEA), commissioned new linear accelerators in two government hospitals under its Cancer Control Plan. This development marks a significant step in improving nationwide access to external beam radiotherapy and highlights Bangladesh’s ongoing efforts to expand and modernize its oncology services through international collaborations
• In January 2024, Sri Lanka’s National Cancer Institute launched its digital radiotherapy planning system with support from global health partners. The system enables more accurate and efficient treatment planning using cloud-based technologies and AI-assisted tools. This advancement reflects Sri Lanka’s focus on elevating treatment precision and adopting modern cancer care protocols in public institutions
• In December 2023, Nepal’s Bhaktapur Cancer Hospital became the first in the country to adopt 3D conformal radiotherapy (3D-CRT) supported by international training programs and donations of treatment planning equipment. This milestone highlights Nepal’s progress toward integrating modern radiotherapy technologies and building local capacity through skilled workforce development and infrastructure enhancement
• In November 2023, Tata Memorial Centre in India entered a research collaboration with leading global medical device manufacturers to pilot AI-based adaptive radiotherapy solutions. The project is designed to improve treatment accuracy and personalize radiotherapy regimens. This collaboration emphasizes India’s growing role in global oncology innovation and reflects the increasing focus on precision medicine in the region’s radiotherapy landscape

SKU-73036